Salusin-β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats

Cardiovascular Research

Volumn 98, Issue 3, 2013, Pages 344-351

  Chen, Wei Wei ^a   Sun, Hai Jian ^a   Zhang, Feng ^a   Zhou, Ye Bo ^a   Xiong, Xiao Qing ^a   Wang, Jue Jin ^a   Zhu, Guo Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Hypertension; Paraventricular nucleus; Salusin; Sympathetic activity; Vasopressin

Indexed keywords

CHLORALOSE; COMPLEMENTARY DNA; IMMUNOGLOBULIN G; LOSARTAN; NORADRENALIN; SALUSIN BETA; UNCLASSIFIED DRUG; URETHAN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SYMPATHETIC NERVE;

HYPERTENSION; PARAVENTRICULAR NUCLEUS; SALUSIN; SYMPATHETIC ACTIVITY; VASOPRESSIN;

ANGIOTENSIN II; ANIMALS; ANTIBODIES; ARGININE VASOPRESSIN; ARTERIAL PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HORMONE ANTAGONISTS; HYPERTENSION, RENOVASCULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 84877978700     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt031     Document Type: Article

References (41)

1. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003; 9:1166-1172.
2. Suzuki N, Shichiri M, Akashi T, Sato K, Sakurada M, Hirono Y et al. Systemic distribution of salusin expression in the rat. Hypertens Res 2007;30:1255-1262.
3. Badoer E. Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 2001;28:95-99.
4. Grisk O. Antihypertensive effects of ACE2 in the paraventricular nucleus: a consequence of reduced neuroinflammation? Cardiovasc Res 2011;92:365-366.
5. Zhong MK, Duan YC, Chen AD, Xu B, Gao XY, De W et al. Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats. Exp Physiol 2008;93:746-753.
6. Zhu GQ, Xu Y, Zhou LM, Li YH, Fan LM, Wang W et al. Enhanced cardiac sympathetic afferent reflex involved in sympathetic overactivity in renovascular hypertensive rats. Exp Physiol 2009;94:785-794.
7. Shi Z, Chen WW, Xiong XQ, Han Y, Zhou YB, Zhang F et al. Sympathetic activation by chemical stimulation of white adipose tissues in rats. J Appl Physiol 2012;112: 1008-1014.
8. Xiong XQ, Chen WW, Han Y, Zhou YB, Zhang F, Gao XY et al. Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension. Hypertension 2012;60:1280-1286.
9. 1 receptors in paraven-tricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats. Exp Physiol 2011;96:94-103.
10. Fan ZD, Zhang L, Shi Z, Gan XB, Gao XY, Zhu GQ. Artificial microRNA interference targeting AT1a receptors in paraventricular nucleus attenuates hypertension in rats. Gene Ther 2012;19:810-817.
11. Suzuki N, Shichiri M, Tateno T, Sato K, Hirata Y. Distinct systemic distribution of salusin-alpha and salusin-beta in the rat. Peptides 2010;32:805-810.
12. Takenoya F, Hori T, Kageyama H, Funahashi H, Takeuchi M, Kitamura Y et al. Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal system. Neu-rosci Lett 2005;385:110-113.
13. Yang C, Talukder MA, Varadharaj S, Velayutham M, Zweier JL. Early ischaemic preconditioning requires Aktand PKA-mediated activation of eNOS via serine1176 phosphorylation. Cardiovasc Res 2013;97:33-43.
14. Yu F, Zhao J, Yang J, Gen B, Wang S, Feng X et al. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul Pept 2004;122:191-197.
15. Izumiyama H, Tanaka H, Egi K, Sunamori M, Hirata Y, Shichiri M. Synthetic salusins as cardiac depressors in rat. Hypertension 2005;45:419-425.
16. Zhang L, Xiong XQ, Fan ZD, Gan XB, Gao XY, Zhu GQ. Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes. J Appl Physiol 2012;113:47-55.
17. Zhou LM, Shi Z, Gao J, Han Y, Yuan N, Gao XY et al. Angiotensin-(1-7) and angio-tensin II in the rostral ventrolateral medulla modulate the cardiac sympathetic afferent reflex and sympathetic activity in rats. Pflugers Arch 2010;459:681-688.
18. Rozance PJ, Limesand SW, Barry JS, Brown LD, Hay WWJr. Glucose replacement to euglycemia causes hypoxia, acidosis, and decreased insulin secretion in fetal sheep with intrauterine growth restriction. Pediatr Res 2009;65:72-78.
19. Sriramula S, Cardinale JP, Lazartigues E, Francis J. ACE2 overexpression in the para-ventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res 2011;92:401-408.
20. Sharma NM, Zheng H, Mehta PP, Li YF, Patel KP. Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II. Cardiovasc Res 2011;92:348-357.
21. Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T et al. The roles of salusins in atherosclerosis and related cardiovascular diseases. J Am Soc Hypertens 2011; 5:359-365.
22. Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S et al. Chronic infusion of salusin-alpha and-beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 2010;212:70-77.
23. Koya T, Miyazaki T, Watanabe T, Shichiri M, Atsumi T, Kim-Kaneyama JR et al. Salusin-beta accelerates inflammatory responses in vascular endothelial cells via NF-kappaB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol 2012;303:H96-H105.
24. Swaab DF, Pool CW, Nijveldt F. Immunofluorescence of vasopressin and oxytocinin the rat hypothalamo-neurohypophypopseal system. J Neural Transm 1975;36:195-215.
25. Noguera I, Medina P, Segarra G, Martinez MC, Aldasoro M, Vila JM et al. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery. Br J Pharmacol 1997;122:431-438.
26. Pyner S. Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation. J Chem Neuroanat 2009;38:197-208.
27. Swanson LW, Sawchenko PE. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 1980;31:410-417.
28. Kumagai H, Suzuki H, Ichikawa M, Nishizawa M, Ryuzaki M, Kumagai K et al. Different responses of renal blood flow and sympathetic nerve activity to captopril and nicar-dipine in conscious renal hypertensive rabbits. J Cardiovasc Pharmacol 1995;25:57-64.
29. Li Z, Bains JS, Ferguson AV. Functional evidence that the angiotensin antagonist losar-tan crosses the blood-brain barrier in the rat. Brain Res Bull 1993;30:33-39.
30. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009;54:690-697.
31. Tanabe S, Shimohigashi Y, Nakayama Y, Makino T, Fujita T, Nose T et al. In vivo and in vitro evidence of blood-brain barrier transport of a novel cationic arginine-vasopressin fragment 4-9 analog. J Pharmacol Exp Ther 1999;290:561-568.
32. Zlokovic BV, Banks WA, el KH, Erchegyi J, Mackic JB, McComb JG et al. Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier. Brain Res 1992;590:213-218.
33. Ermisch A. Peptide receptors of the blood-brain barrier and substrate transport into the brain. Prog Brain Res 1992;91:155-161.
34. van Bree JB, de Boer AG, Verhoef JC, Danhof M, Breimer DD. Transport of vasopres-sin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells. J Pharmacol Exp Ther 1989;249:901-905.
35. Banks WA, Kastin AJ, Horvath A, Michals EA. Carrier-mediated transport of vasopres-sin across the blood-brain barrier of the mouse. J Neurosci Res 1987;18:326-332.
36. Mens WB, Witter A, van Wimersma Greidanus TB. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res 1983;262:143-149.
37. Marina N, Abdala AP, Korsak A, Simms AE, Allen AM, Paton JF et al. Control of sympathetic vasomotor tone by catecholaminergic C1 neurones of the rostral ventrolat-eral medulla oblongata. Cardiovasc Res 2011;91:703-710.
38. Gomez RE, Cannata MA, Milner TA, Anwar M, Reis DJ, Ruggiero DA. Vasopressiner-gic mechanisms in the nucleus reticularis lateralis in blood pressure control. Brain Res 1993;604:90-105.
39. Kc P, Balan KV, Tjoe SS, Martin RJ, Lamanna JC, Haxhiu MA et al. Increased vasopres-sin transmission from the paraventricular nucleus to the rostral medulla augments cardiorespiratory outflow in chronic intermittent hypoxia-conditioned rats. J Physiol 2010;588:725-740.
40. Andreatta-Van LS, Averill DB, Ferrario CM. Cardiovascular actions of vasopressin at the ventrolateral medulla. Hypertension 1990;15:I102-I106.
41. Yang Z, Bertram D, Coote JH. The role of glutamate and vasopressin in the excitation of RVL neurones by paraventricular neurones. Brain Res 2001;908:99-103.